News Release: July 27, 2025
Myricetin Price Trend and Production News
(For full analysis, visit: Myricetin price trend and production News)
Myricetin Price Trend in Past Five Years and Factors Impacting Price Movements
Over the past five years, the Myricetin price trend has reflected a highly dynamic market influenced by a combination of supply-side constraints, fluctuating raw material costs, and changing demand from key end-use sectors such as nutraceuticals, cosmetics, and pharmaceuticals.
In 2020, Myricetin prices averaged around $2,300/MT. This was largely a stable period, although demand was temporarily affected due to the pandemic-induced supply chain disruptions. By 2021, prices increased to approximately $2,650/MT, as countries began easing lockdowns and industrial production ramped up, causing a surge in demand for bioflavonoids used in health supplements.
In 2022, Myricetin price news began highlighting sharp cost increases due to supply chain bottlenecks from Asia, especially China, which is a major production hub. Prices surged to around $3,200/MT. The shortage of certain botanical extracts and higher extraction costs caused further tightening in supply. Additionally, environmental regulations and labor shortages in Asia led to delayed harvest and extraction of plant-based raw materials.
In 2023, the average Myricetin price trend continued to climb, reaching nearly $3,750/MT. This was also the year where green chemistry methods gained traction. However, these more sustainable but expensive production methods increased operational costs. Simultaneously, the rise in demand from pharmaceutical manufacturers pushing for antioxidant-based compounds added upward pressure on pricing.
By 2024, a slight moderation was observed in Myricetin price news, settling around $3,500/MT as production capacity expanded in Eastern Europe and Southeast Asia. Moreover, improved cultivation practices and decentralized sourcing in India and South America began to contribute to cost stabilization. New manufacturing facilities became operational in Vietnam and Poland, marginally reducing price volatility.
Now in 2025, the average global Myricetin price stands at approximately $3,450/MT. The current outlook suggests a relatively balanced supply-demand dynamic, though periodic spikes are still possible, especially due to climatic unpredictability in key raw material sourcing regions and fluctuations in fuel and transportation charges.
Factors that have consistently impacted Myricetin price trends over the years include:
- Fluctuations in the cost and availability of natural sources like Myrica rubra and other plant materials.
- Global shipping and freight costs.
- Advances in extraction technology, which initially raise production costs before scaling down.
- Increased Myricetin sales volume in therapeutic and dietary supplement industries.
- Trade policies and phytochemical export regulations in major producing countries.
Looking forward, prices are likely to remain within a narrow band between $3,400–$3,600/MT in the short term, barring any major economic or climate disruptions.
Myricetin Price Trend Quarterly Update in $/MT (2025 Estimates)
- Q1 2025: $3,480/MT
- Q2 2025: $3,460/MT
- Q3 2025: $3,440/MT (estimated)
- Q4 2025: $3,500/MT (projected)
The quarterly Myricetin price news indicates mild price fluctuations due to seasonal variation in raw material harvests and moderate changes in international trade tariffs. Global buyers are increasingly placing bulk orders ahead of seasonal demand, mildly stabilizing short-term volatility. Q3 is anticipated to record the lowest quarterly price due to oversupply from new Asian producers entering the market.
Global Myricetin Import-Export Business Overview
The global Myricetin import-export business has evolved into a competitive segment, driven by growing applications in health and wellness markets. This bioflavonoid, known for its antioxidant properties, has seen expanding consumption in the nutraceutical and pharmaceutical industries, leading to increased cross-border trade. Myricetin is mostly exported as a purified extract or powder, often standardized to meet pharmaceutical-grade specifications.
In 2021, China emerged as the largest exporter of Myricetin, contributing nearly 45% of the global export share. Chinese producers leveraged low-cost extraction technologies and access to abundant raw materials to capture a significant chunk of the market. By 2023, however, stringent environmental regulations in China led to a slight contraction in supply, pushing international buyers to diversify sourcing from India, Brazil, and Eastern Europe.
India has significantly increased its footprint in the Myricetin export landscape. The Indian phytochemicals industry, supported by government subsidies and tax exemptions for herbal extract units, has ramped up exports to North America and the EU. India’s Myricetin exports in 2024 totaled over 1,200 MT, an impressive leap from just 650 MT in 2021.
On the import side, the United States and Germany remain key importers, driven by demand from dietary supplement manufacturers. US-based supplement companies prefer high-purity Myricetin standardized to 98% or above. In contrast, European buyers often opt for semi-refined variants blended into plant-based formulations.
The average Myricetin sales volume globally has been on a steady rise, from around 5,000 MT in 2020 to more than 7,800 MT in 2024. This increase is largely attributed to heightened health awareness post-COVID-19 and a shift toward natural antioxidant supplements.
Myricetin production is now witnessing geographical diversification. While China continues to be a major player, new production facilities have been commissioned in Poland, Vietnam, and Mexico. These nations offer lower export tariffs and favorable trade agreements with the US and EU. Poland, in particular, has emerged as a hub for EU-bound exports, with production facilities adhering to strict EU GMP standards.
Recent Myricetin price news also underscores how trade negotiations are impacting global prices. For instance, the introduction of new bilateral trade agreements between ASEAN countries and Europe in 2024 has led to reduced import duties for botanical compounds, including Myricetin. This has enabled ASEAN producers to increase exports at competitive prices.
Importers have also started to show preference for vertically integrated suppliers who control the full chain from cultivation to final extraction. This trend has been most evident in South Korea and Japan, where Myricetin importers demand traceability and sustainability certification.
However, some challenges remain. In South America, inconsistent production cycles due to climatic issues have affected the export reliability of Brazil and Argentina. Additionally, political instability in some African nations with potential for botanical exports has deterred long-term contracts.
As per recent trade statistics for 2025:
- China exported approximately 3,200 MT of Myricetin.
- India followed with 1,350 MT of exports.
- Vietnam and Poland contributed 800 MT and 650 MT respectively.
- The United States imported about 2,500 MT.
- Germany and France combined imported over 1,700 MT.
- South Korea imported 600 MT, primarily for pharmaceutical formulation use.
Market analysts expect a steady increase in Myricetin production over the next 3 years. New extraction methods involving enzymatic biotransformation are under pilot-scale testing in laboratories across the US and Germany. If successful, they are expected to lower processing costs and enhance purity levels, which will directly impact the long-term Myricetin price trend.
Another notable trend shaping the import-export dynamic is the rise in contract manufacturing and white-label packaging. Exporters from India and Vietnam are increasingly offering full-service packages including extraction, formulation, and branded packaging, catering especially to SMEs in the supplement sector in the US and EU.
In summary, the Myricetin import-export market in 2025 is defined by diversification of supply, moderate price stability, and evolving regulatory frameworks. As Myricetin gains further clinical validation, its cross-border trade volume is expected to rise, with particular growth anticipated in Southeast Asia and Eastern Europe.
To request a sample and view full data, visit:
https://datavagyanik.com/reports/myricetin-market-size-production-sales-average-product-price-market-share-import-vs-export/
Myricetin Production Trends by Geography
In recent years, Myricetin production has expanded considerably due to increasing global demand driven by the health, pharmaceutical, and nutraceutical industries. As a naturally occurring flavonoid with antioxidant and anti-inflammatory properties, Myricetin is extracted from a variety of plant sources such as bayberry, tea, fruits, and vegetables. The global production landscape is shifting as countries invest in phytochemical extraction technologies and diversify their botanical sourcing strategies. The current production trends are shaped by regional resource availability, processing capabilities, and government support for natural product industries.
China remains the largest producer of Myricetin globally. The country’s vast herbal extraction infrastructure, abundant availability of native plant sources like Myrica rubra, and relatively low labor costs provide it a competitive edge. Chinese production clusters are primarily based in the eastern and southern provinces, where climate conditions favor year-round harvesting of raw materials. The government’s support for traditional Chinese medicine and exports of botanical products continues to encourage Myricetin manufacturing. However, stricter environmental regulations and rising extraction costs have led some producers to seek more energy-efficient and eco-friendly processing technologies.
India has emerged as a strong contender in the Myricetin production landscape. The country’s Ayurvedic and herbal extract sector has grown rapidly, supported by favorable policies and tax incentives. Indian manufacturers primarily produce Myricetin for export, sourcing raw materials from diverse agro-climatic zones in Kerala, Tamil Nadu, and the Himalayan belt. Local R&D institutions have also improved extraction yields using green chemistry methods, making India an increasingly attractive destination for cost-effective and high-purity Myricetin production.
Vietnam and Thailand are expanding their presence as regional producers in Southeast Asia. Vietnam, in particular, has seen a rise in Myricetin production due to its biodiversity and strategic investments in herbal pharmaceutical infrastructure. With the support of foreign direct investments and trade partnerships with the EU and the U.S., the country has scaled up manufacturing to cater to the growing demand in international markets.
In Europe, Poland and Germany are developing into niche producers of Myricetin, especially for high-purity pharmaceutical and cosmetic-grade applications. Poland’s production is primarily export-oriented, with processing facilities aligned to EU GMP standards. German companies focus on sustainable production processes and traceability, appealing to health-conscious and regulatory-sensitive markets.
The United States is not a major producer but has limited domestic production for research and niche applications. Most of the U.S. market demand is met through imports, though a few biotech firms in California and the Midwest are experimenting with enzymatic biosynthesis to produce Myricetin without relying on plant extraction.
Brazil and Argentina represent Latin America’s contribution to Myricetin production. Both countries offer rich biodiversity and cost-effective labor, although production remains inconsistent due to irregular climatic conditions and supply chain challenges. Brazil has a higher production capacity, often focused on semi-refined extracts used in cosmetics and functional foods.
In Africa, countries like South Africa and Kenya are beginning to explore Myricetin production through pilot-scale herbal extraction projects. However, production is still in its infancy, largely targeting domestic consumption or small-scale exports to Europe.
Overall, the Myricetin production map is becoming more decentralized. While China continues to dominate in volume, other regions are gaining ground by focusing on sustainable practices, high-purity standards, and strategic trade alliances. The increasing importance of certification, traceability, and environmental compliance is likely to redefine regional dominance in the coming years.
Myricetin Market Segmentation
Key Segments of the Myricetin Market:
- By Application
- Nutraceuticals
- Pharmaceuticals
- Cosmetics & Personal Care
- Food & Beverages
- Research & Laboratory Use
- By Form
- Powder
- Capsules
- Tablets
- Liquid Extract
- By Purity
- Below 90%
- 90% – 98%
- Above 98%
- By End-User
- Individual Consumers
- Contract Manufacturers
- Retailers/Wholesalers
- Healthcare Institutions
- By Distribution Channel
- Online Retail
- Offline Pharmacies & Health Stores
- B2B Bulk Supply
Leading Segment Explanations
Nutraceuticals dominate the Myricetin market by application. This segment has witnessed rapid growth due to the rising global trend toward preventive healthcare and natural antioxidant supplementation. Myricetin is frequently included in formulations promoting cardiovascular health, immune support, and anti-aging. The bioavailability of Myricetin when combined with other flavonoids or vitamin complexes enhances its appeal in health supplements. North America and Europe have shown strong consumer demand in this segment, leading to higher Myricetin sales volume across multiple distribution channels.
Pharmaceuticals represent the second most prominent application segment. Clinical research continues to explore the anti-cancer, neuroprotective, and anti-inflammatory properties of Myricetin. Several pharmaceutical companies have introduced Myricetin-based formulations as adjunct therapies for chronic diseases. The demand for pharmaceutical-grade Myricetin with purity levels above 98% is growing, especially in regulated markets like the U.S., Germany, and Japan. This segment also supports the ongoing development of novel drug delivery systems using nano-encapsulated Myricetin, further boosting long-term demand.
Cosmetics and personal care applications are increasingly integrating Myricetin into skincare and anti-aging products. Its antioxidant and anti-photoaging effects make it suitable for serums, creams, and lotions targeting sensitive skin and UV protection. Asia-Pacific is a key driver in this segment, with South Korea and Japan leading the trend toward natural and clean-label skincare products. European cosmetic brands are also sourcing sustainable, certified Myricetin for high-end product lines.
In terms of form, powdered Myricetin leads the market due to its ease of formulation and extended shelf life. Powder is the preferred form in both B2B and B2C segments, used widely in dietary supplements, beverages, and cosmetic formulations. Capsules and tablets follow closely, primarily consumed by individual users seeking convenient dosing formats.
Liquid extracts are gaining ground in specialized applications such as tinctures and skincare serums. These are more common in North America and Europe, where consumers prefer organic and fast-absorbing formulations.
The purity-based segmentation shows that the 90%–98% range accounts for the largest market share. This purity level offers a good balance between efficacy and cost, making it ideal for nutraceutical and food applications. However, demand for above 98% purity is rising within pharmaceuticals and cosmeceuticals due to strict regulatory standards and the need for maximum potency.
Among end-users, contract manufacturers and bulk buyers dominate. Many supplement and cosmetic brands outsource production and rely on contract manufacturers for consistent quality and scalability. Individual consumers constitute a smaller but steadily growing portion, especially in developed markets where online platforms allow for direct access to high-quality Myricetin products.
The distribution channel segmentation is witnessing rapid transformation. Online retail platforms, including health product portals and e-commerce giants, have expanded accessibility to Myricetin supplements globally. Bulk B2B channels continue to drive the majority of sales volume, especially in North America, Europe, and Southeast Asia. Offline health stores and pharmacies remain significant, particularly in countries with established traditional medicine frameworks.
In conclusion, the Myricetin market is segmented across multiple dimensions, each contributing uniquely to overall market dynamics. While nutraceuticals and pharmaceuticals remain the key drivers in terms of volume and revenue, cosmetics and food applications are poised for faster growth. The increasing emphasis on purity, formulation versatility, and targeted delivery systems will continue to shape segment preferences. With more consumers and businesses opting for natural and functional ingredients, the Myricetin market is expected to maintain strong momentum across all major segments.
For detailed data and sample request, visit:
https://datavagyanik.com/reports/myricetin-market-size-production-sales-average-product-price-market-share-import-vs-export/